These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4056047)

  • 1. Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism.
    Akmal M; Telfer N; Ansari AN; Massry SG
    J Clin Invest; 1985 Oct; 76(4):1695-8. PubMed ID: 4056047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of parathyroid hormone in the glucose intolerance of chronic renal failure.
    Akmal M; Massry SG; Goldstein DA; Fanti P; Weisz A; DeFronzo RA
    J Clin Invest; 1985 Mar; 75(3):1037-44. PubMed ID: 3884663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of relation between secondary hyperparathyroidism and red blood cell osmotic fragility in chronic renal failure.
    Docci D; Turci F; Baldrati L
    Nephron; 1985; 41(3):241-5. PubMed ID: 3840575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
    Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
    Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure.
    Akmal M; Kasim SE; Soliman AR; Massry SG
    Kidney Int; 1990 Mar; 37(3):854-8. PubMed ID: 2313975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
    Docci D; del Vecchio C; Salvi P; Turci F; Salvi G; Cenciotti L; Pretolani E
    Clin Nephrol; 1985 Feb; 23(2):68-73. PubMed ID: 3987101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
    Monier-Faugere MC; Geng Z; Friedler RM; Qi Q; Kubodera N; Slatopolsky E; Malluche HH
    Kidney Int; 1999 Mar; 55(3):821-32. PubMed ID: 10027919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
    Zucchi C
    Minerva Med; 1985 Mar; 76(9-10):397-401. PubMed ID: 3982697
    [No Abstract]   [Full Text] [Related]  

  • 10. [Calcium and the parathyroid gland in hemodialysis].
    Nagata N; Nakamura K; Kawakami K
    Nihon Rinsho; 1972 Dec; 30(12):2495-500. PubMed ID: 4569588
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of endothelin receptor antagonist on parathyroid gland growth, PTH values and cell proliferation in azotemic rats.
    Jara A; von Höveling A; Jara X; Burgos ME; Valdivieso A; Mezzano S; Felsenfeld AJ
    Nephrol Dial Transplant; 2006 Apr; 21(4):917-23. PubMed ID: 16431896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of secondary hyperparathyroidism in chronic renal failure.
    Rahamimov R; Silver J
    Isr J Med Sci; 1994 Jan; 30(1):26-31. PubMed ID: 8138394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of inorganic sulphate in the pathogenesis of hyperparathyroidism in chronic renal failure.
    Michalk D; Tschöpe W; Böhles HJ; Mehls O
    Proc Eur Dial Transplant Assoc; 1981; 18():561-6. PubMed ID: 7329984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of parathyroid hormone on osmotic fragility of human erythrocytes.
    Bogin E; Massry SG; Levi J; Djaldeti M; Bristol G; Smith J
    J Clin Invest; 1982 Apr; 69(4):1017-25. PubMed ID: 6281309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of secondary hyperparathyroidism with red cell survival in chronic haemodialysis patients.
    Saltissi D; Carter GD
    Clin Sci (Lond); 1985 Jan; 68(1):29-33. PubMed ID: 3964727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeostasis and action of parathyroid hormone in normal man and patients with mild renal failure.
    Massry SG; Llach F; Singer FR; Kurokawa K; Coburn JW
    Proc Eur Dial Transplant Assoc; 1975; 11():451-6. PubMed ID: 812084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of parathyroid hormone in the anemia of chronic terminal renal dysfunction in dogs.
    Petrites-Murphy MB; Pierce KR; Lowry SR; Fisher JW
    Am J Vet Res; 1989 Nov; 50(11):1898-905. PubMed ID: 2619121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
    J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
    Lindberg JS; Moe SM; Goodman WG; Coburn JW; Sprague SM; Liu W; Blaisdell PW; Brenner RM; Turner SA; Martin KJ
    Kidney Int; 2003 Jan; 63(1):248-54. PubMed ID: 12472790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistant abnormal serum parathyroid hormone after renal transplantation: correlation between renal graft function.
    Cheng CH; Lian JD; Yang YF; Shu KH; Lu YS; Chen DL
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):81-4. PubMed ID: 2670141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.